In the B16 melanoma model, Quezada et al. showed that the cell line used in their experiments expressed MHC class II, but only when the tumor-bearing hosts were subjected to a combination of irradiation and adoptive transfer of Trp1-specific CD4+ T cells together with anti-CTLA mAb (37). This evidence concerns the gene TYRP1 and melanoma.